INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

7,671 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
42
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$1.27M
3,780 sh
Jan 14, 2026Jan 15, 2026
Page 141 of 192
← PrevNext →
traded Jan 14, 2026
+1d
SEC Form 4

Evidence

42
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$2.64M
7,820 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

42
WJ
Weber Clifford JohnTrustee
GLOClough Global Opportunities Fund
Open-market purchase
BUY$6,000
1,000 sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

40
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$8.31M
96.0K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

38
DP
Donohoe Bryan PatrickChief Executive Officer
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$107K
21.8K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

36
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$3,664
745 sh
Jan 2, 2025Jan 15, 2026
traded Jan 2, 2025
+378dSEC Form 4

Evidence

35
EW
Eager William WPresident, S&P Global Mobility
SPGIS&P Global Inc.
Open-market purchase
BUY$5,964
12 sh
Dec 10, 2025Jan 15, 2026
traded Dec 10, 2025
+36dSEC Form 4

Evidence

35
FA
Feingold AntonGen. Counsel VP and Secretary
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$37K
7,606 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

35
GM
Gonzales Jeffrey MichaelCFO and Treasurer
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$31K
6,218 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

34
KC
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$107K
3,822 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

33
AS
Acevedo SylviaDirector
CRDOCredo Technology Group Holding Ltd
Open-market sale
SELL$178K
1,100 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

33
AS
Acevedo SylviaDirector
CRDOCredo Technology Group Holding Ltd
Open-market sale
SELL$172K
1,100 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

32
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$1,901
685 sh
Apr 1, 2025Jan 15, 2026
traded Apr 1, 2025
+289dSEC Form 4

Evidence

32
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
12.5K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

32
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$4,820
1,553 sh
Mar 19, 2025Jan 15, 2026
traded Mar 19, 2025
+302dSEC Form 4

Evidence

31
SS
Sijbrandij SytseDirector, 10% Owner
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$1.59M
44.2K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

30
TB
Tighe BrettChief Financial Officer
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$951K
10.0K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

30
SM
Sharma ManishChief Strategy & Services Ofcr
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$336K
1,161 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

51
FP
Feinberg PeterDirector
IMRXImmuneering Corp
Open-market purchase
BUY$87K
20.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

49
HD
Hildebrandt John DPresident and COO
PSMTPRICESMART INC
Open-market sale
SELL$1.02M
7,421 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

48
DA
DiGravio Karen AnnTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$3,062
378 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

46
KP
Kovaleski PaulEVP-Chief Merch. Officer
PSMTPRICESMART INC
Open-market sale
SELL$582K
4,255 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

46
IV
Infante Beatriz VDirector
PSMTPRICESMART INC
Open-market sale
SELL$273K
1,995 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

44
BR
Brumana RodrigoChief Financial Officer
JOBYJoby Aviation, Inc.
Open-market sale
SELL$7,756
523 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

43
DP
Duffy Sean P.Director, Chief Executive Officer
OMDAOmada Health, Inc.
Open-market sale
SELL$2.15M
140.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

43
DP
Duffy Sean P.Director, Chief Executive Officer
OMDAOmada Health, Inc.
Open-market sale
SELL$1.45M
90.5K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

43
BL
Baller LanceDirector, 10% Owner
GBCSSELECTIS HEALTH, INC.
Open-market purchase
BUY$14K
6,192 sh
Dec 18, 2025Jan 14, 2026
traded Dec 18, 2025
+27dSEC Form 4

Evidence

40
MC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$1.37M
49.8K sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

40
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$204K
11 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
PV
Poulton Jeffrey V.EVP, Chief Financial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$133K
365 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
PV
Poulton Jeffrey V.EVP, Chief Financial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$56K
156 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
PV
Poulton Jeffrey V.EVP, Chief Financial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$63K
176 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
FM
Frank MalcolmDirector
FDSFACTSET RESEARCH SYSTEMS INC
Open-market sale
SELL$452K
1,527 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
GP
Garg PushkalEVP Chief R&D
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$73K
199 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
PV
Poulton Jeffrey V.EVP, Chief Financial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$63K
170 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
PV
Poulton Jeffrey V.EVP, Chief Financial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$81K
226 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
PV
Poulton Jeffrey V.EVP, Chief Financial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$102K
284 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
BJ
Bricker JudeDirector, Chief Executive Officer
SNCYSun Country Airlines Holdings, Inc.
Open-market sale
SELL$89K
5,062 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
TT
Tanguler TolgaEVP, Chief Commercial Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$73K
199 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

39
GP
Garg PushkalEVP Chief R&D
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale
SELL$80K
220 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence